Streetbeat News

Products Services

MRK

Merck has released results from its Phase 2 KeyVibe-002 trial, which assesses a coformulation of vibostolimab and pembrolizumab for treating metastatic non-small cell lung cancer. The findings are crucial for the company's oncology portfolio and could influence its future treatment offerings for this type of cancer.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:05 am

BEEM

Beam Global announced that it has received repeat orders for its EV ARC solar-powered EV charging systems from multiple federal agencies. This indicates ongoing demand and trust in Beam's technology from government clients, which could lead to increased visibility and potentially more orders in the future.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 11:02 am

GNFT

IPSEY

Ipsen and GENFIT announced the FDA has accepted the NDA for elafibranor, a potential treatment for PBC, a rare liver disease. The FDA granted priority review with a target PDUFA date of June 10, 2024.

Portfolio Pulse from Charles Gross

December 07, 2023 | 10:17 am

EWJ

Nikkei reported that a company referred to as 'X' is planning to establish an app development team in Japan, as stated by CEO Linda Yaccarino. The specifics of the company's plans, including the scale of investment or the strategic importance of this move, were not detailed in the provided information.

Portfolio Pulse from Charles Gross

December 07, 2023 | 10:01 am

AAPL

Apple Inc. has announced a collaboration with TDK Corporation for the production of lithium-ion battery cells in India, which will be used to power locally assembled iPhones. The production is expected to start within 12-18 months. TDK, after acquiring Amperex Technology Ltd, is setting up a facility in Haryana, India, which will create direct employment for 8,000-10,000 people and indirectly support over 25,000 jobs. This move is part of Apple's strategy to reduce reliance on China and increase the domestic value addition of iPhones assembled in India, which currently stands at 12-15%. TDK controls over 60% of the global Li-ion cell market, and this partnership is a significant step in diversifying Apple's supply chain.

Portfolio Pulse from Shomik Sen Bhattacharjee

December 07, 2023 | 9:59 am

META

The Wall Street Journal reports that Meta Platforms Inc. will begin fully encrypting messages on Facebook and Instagram. This move towards enhanced privacy could affect user trust and regulatory scrutiny.

Portfolio Pulse from Charles Gross

December 07, 2023 | 9:50 am

MCD

McDonald's Corporation (NYSE:MCD) is launching a new restaurant concept called CosMc's, focusing on to-go dining and iced drinks without traditional fries and burgers. The first location will open in a Chicago suburb with four drive-through lanes and no dining area. CosMc's aims to tap into the specialty beverages and coffee market, leveraging a revived orange alien mascot from past advertisements. McDonald's plans to open approximately ten more locations in Texas by next year. The move follows strong Q2 financial results, with sales up 14% year-over-year to $6.5 billion.

Portfolio Pulse from Benzinga Neuro

December 07, 2023 | 9:24 am

GOOG

GOOGL

META

Google's Gemini AI is now available on the Pixel 8 Pro, offering Smart Reply features in WhatsApp and live transcription summaries in the Recorder app. The AI operates on-device, enhancing privacy and efficiency. Users can enable Gemini AI by activating Developer Options and enabling AICore Persistent. Google plans to expand Gemini AI features in the future.

Portfolio Pulse from Rounak Jain

December 07, 2023 | 9:02 am

DOGEUSD

FLOKIUSD

SOLUSD

A cryptocurrency analyst suggested that FLOKI, a meme coin, could surge by 40%, drawing parallels to the price movements of Solana's meme coin BONK. The prediction is based on structural similarities in their market behavior and recent price actions. Dogecoin's rise to $0.10 has also been noted as a positive sign for meme coins. Additionally, Floki's Head of Operations discussed the strategic launch timing for their play-to-earn NFT game Valhalla, emphasizing its importance to Floki's future.

Portfolio Pulse from Mehab Qureshi

December 07, 2023 | 7:45 am

REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will present new and updated data on its oncology pipeline at the ESMO IO Congress 2023. This includes Phase 1 data for REGN5668 in combination with Libtayo in recurrent ovarian cancer patients and Phase 2 trial results of Libtayo with SBRT in early-stage HCC patients.

Portfolio Pulse from Benzinga Newsdesk

December 07, 2023 | 7:38 am